Differences In Androgen Levels Research Articles

Androgen dihydrotestosterone promotes bladder cancer cell proliferation and invasion via EPPK1-mediated MAPK/JUP signalling

The incidence of bladder cancer (BLCA) in men is higher than that in women. Differences in androgen levels between men and women are considered the main causes of incidence rate differences. In this study, dihydrotestosterone (DHT) significantly increased the proliferation and invasion of BLCA cells. In addition, BLCA formation and metastatic rates were higher in N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN)-treated male mice than in female and castrated male mice in vivo. However, immunohistochemistry showed that androgen receptor (AR) was expressed at low levels in normal and BLCA tissues of men and women. The classical AR pathway considers that DHT binds to AR and induces it to enter the nucleus, where it functions as a transcription factor. Here, a non-AR combination pathway of androgen that promoted BLCA development was investigated. The EPPK1 protein was bombarded with DHT, as determined by biotinylated DHT-binding pull-down experiments. EPPK1 was highly expressed in BLCA tissues, and EPPK1 knockdown significantly inhibited BLCA cell proliferation and invasion promoted by DHT. Moreover, JUP expression was elevated in DHT-treated high-EPPK1 expressing cells, and JUP knockdown inhibited cell proliferation and invasion. EPPK1 overexpression increased tumour growth and JUP expression in nude mice. Furthermore, DHT increased the expression of the MAPK signals p38, p-p38, and c-Jun, and c-Jun could bind to the JUP promoter. However, the promotion of p38, p-p38, and c-Jun expression by DHT was not observed in EPPK1 knockdown cells, and a p38 inhibitor suppressed the DHT-induced effects, indicating that p38 MAPK may be involved in the regulation of DHT-dependent EPPK1-JUP-promoted BLCA cell proliferation and invasion. The growth of bladder tumours in BBN-treated mice was inhibited by the addition of the hormone inhibitor goserelin. Our findings indicated the potential oncogenic role and mechanism of DHT in BLCA pathogenesis through a non-AR pathway, which may serve as a novel therapeutic target for BLCA.

Anthropogenic impact on the reproductive health of two wild Patagonian fish species with differing reproductive strategies

A particularly concerning outcome of environmental pollution is the disturbance of reproductive processes. However, studies on the impacts of pollution on the reproductive health of fish inhabiting South American environments are limited. We studied the impact of anthropogenic pollution on the reproductive health of two sympatric Patagonian marine fish species with different reproductive strategies: the live-bearing rockfish Sebastes oculatus and the egg-laying Brazilian sandperch Pinguipes brasilianus. Our findings reveal that both species presented some degree of reproductive disturbance when inhabiting an affected site, but the specific alterations differed depending on the species, sex, and season. During the reproductive season, 17β-estradiol levels were elevated in females of both species living in polluted areas, while no differences in androgen levels were observed in either species or season. The gonadosomatic index (GSI) was affected in both sexes of S. oculatus during the non-reproductive season, while the gonadal stages were mainly affected in both sexes of P. brasilianus. No signs of intersex condition were observed. Our results highlight the importance of including diverse reproductive parameters to better understand anthropogenic effects on wild animals. Long-term studies including other fish species and including offspring (to evaluate possible transgenerational effects) will be necessary to determine the consequences of the documented reproductive alterations, particularly whether fish species inhabiting Patagonian marine reef areas will be able to reproductively adapt to increasing marine anthropogenic disturbances.

Evaluation of Hyperandrogenism in Children with Autism Spectrum Disorder.

This study evaluated 32 children (mean age: 8.5 y) with autism spectrum disorder (ASD) and 23 healthy controls (similar age, sex, and Tanner stage) for hyperandrogenism. These children underwent sexual maturity rating (Tanner staging), ASD severity assessment (Childhood Autism Rating Scale), and quantitative estimation for plasma testosterone, dehydroepiandrosterone sulfate (DHEAS), and androstenedione. There was no significant difference in androgen levels in the two groups. Elevated (> 95 centiles) testosterone, DHEAS, and androstenedione levels were seen in 12.3%, 6.2%, and 9% children with ASD, and 7/9 of these children (78%) with hyperandrogenism had severe ASD. However, there was no significant correlation between ASD severity and androgen levels.

Characteristics of song, brain-anatomy and blood androgen levels in spontaneously singing female canaries

Females of many northern temperate songbird species sing sporadically. However, detailed descriptions of female song are rare. Here we report a detailed analysis of song in a small number of spontaneously-singing female domesticated canaries (Serinus canaria) under non-breeding, laboratory conditions in a large population of domesticated birds. In-depth analysis showed that these females sang rarely, and the spontaneous songs varied between and within birds over time. Furthermore, spontaneous female songs were distinct from songs of testosterone-induced singing female canaries and from songs of male canaries in both temporal and spectral features. Singing females had significantly elevated plasma androgen levels and a larger size of the major song controlling brain nuclei HVC (used as a proper name) and the robust nucleus of the arcopallium (RA) than non-singing females housed under similar conditions. The sporadically observed production of song and accompanying differences in brain anatomy in female canaries may thus depend on minute intraspecific differences in androgen levels.

Clinical, biochemical and gender characteristics of 97 prepubertal children with premature adrenarche.

Background Premature adrenarche (PA) is defined as the appearance of clinical signs of androgen action associated with levels of dehydroepiandrosterone sulfate (DHEAS) ≥40 μg/dL, before age 8 years in girls and 9 years in boys, without breast or testicular enlargement. The aim of this study was to characterize a population of prepubertal Caucasian children with PA and to compare them with regard to gender and body mass index (BMI) (normal BMI vs. overweight/obesity). Methods We performed a cross-sectional study of Portuguese Caucasian prepubertal children followed, due to PA, in pediatric endocrinology clinics of a university hospital. Results Eighty-two girls and 15 boys were included (mean age at evaluation: 7.4 ± 1.3 years). The mean birth weight was 2990 ± 689 g; only two children were small for gestational age. Girls presented premature pubarche at a younger age (median [interquartile range (IQR)] 6 (5-6) years vs. 7 (7-8) years in boys; p < 0.001). No gender differences were found for gestational age, birth weight, maternal age at menarche, anthropometry, bone age advancement or androgen levels. The majority of the subjects were overweight or obese (59%). Overweight/obese PA children were taller and had a more advanced bone age than normal-BMI PA children. Overweight/obese children presented higher levels of DHEAS and androstenedione. Bone age advancement and DHEAS were correlated (r = 0.449; p = 0.05). Conclusions We found no evidence of reduced fetal growth. Girls presented premature pubarche at a younger age. No major gender differences in androgen levels were found in prepuberty. Obese and overweight PA children tend to be taller, have a more advanced bone age and higher levels of androgens than normal-BMI PA children.

Why do High IQ Societies Differ in Intellectual Achievement? The Role of Schizophrenia and Left‐Handedness in Per Capita Scientific Publications and Nobel Prizes

AbstractPrevious research has attempted to understand why countries with relatively favorable conditions and high estimated average IQs (such as Finland and Japan) have a relatively low per capita number of scientific Nobel prizes. In the present study, we examine whether there is a relationship between national schizophrenia and left‐handedness prevalence, on the one hand, and per capita scientific and literary achievement, on the other hand, in countries with IQ estimates of at least 90. We found that per capita science and literature Nobel prizes and scientific publications are strongly negatively associated with schizophrenia and strongly positively correlated with left‐handedness. There also was a very pronounced negative correlation between schizophrenia rate and left‐handedness rate. These results suggest that genius can be regarded as a combination of very high IQ, aspects of high‐functioning autism (specifically low empathy) plus relatively low impulse control, consistent with observations of intellectually outstanding individuals, and the fact that schizophrenia appears to constitute the opposite pole of these aspects of autism spectrum. We posit differences in androgen levels as a possible underlying explanation for these findings.

131 Differences in Androgen Levels and Sexual Function between North American and European Men

Previous studies have indicated sex steroid levels vary by geographic location, suggesting environmental factors may play a role in hormone production. Despite this, few studies have evaluated the association of androgen levels and sexual function with geographic location. To identify the differences in baseline androgen levels and sexual function between North American and European men in the Reduction by Dutasteride in Prostate Cancer Events (REDUCE) Study. We evaluated data of 5,825 men in the REDUCE study, which included subjects aged 50-75 years with prostate-specific antigen levels of 2.5-10 ng/mL (50-60 years) or 3.0-10 ng/mL (60-75 years) and a negative baseline prostate biopsy. Subjects were divided in two groups: North Americans and Europeans. Differences in baseline demographics, comorbidities, laboratory results and questionnaire-based sexual function (Problem Assessment Scale of Sexual Function Index: PAS-SFI) between groups were evaluated using analysis of variance and chi-square tests in univariable analysis, and linear and logistic regressions in multivariable analysis. Subgroup analyses further dividing Europeans into Eastern and Western were performed as above.

Comparison of Androgen Levels, Endocrine and Metabolic Indices, and Clinical Findings in Women with Polycystic Ovary Syndrome in Uygur and Han Ethnic Groups from Xinjiang Province in China.

BackgroundThe aim of this study was to compare androgen levels, endocrine and metabolic indices, and clinical findings in women with polycystic ovary syndrome (PCOS) in Uygur and Han ethnic groups from Xinjiang Province, China.Material/MethodsBetween January 2016 to May 2017 clinical data were collected from Uygur (N=82) and Han (N=100) women diagnosed with PCOS, including age, body mass index (BMI), the Ferriman-Gallwey (mFG) hirsutism score, and waist-to-hip ratio (WHR). Blood samples obtained from all study participants were used to measure androgenic steroid levels, including androgen, androstenedione, dehydroepiandrosterone (DHEA), dihydrotestosterone (DHT), and the free androgen index (FAI). Endocrine indices measured included sex-hormone binding globulin (SHBG), luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol (E2), and prolactin (PL). Metabolic indices measured included insulin, glucose, total cholesterol (TC), triglyceride (TG), high-density lipoprotein (HDL), triglyceride (TG), and low-density lipoprotein (LDL).ResultsThe FAI in Uygur women with PCOS (4.89) was significantly increased compared with Han women with PCOS (2.78) (p<0.05); androgen levels were significantly correlated with the FAI, glucose, insulin, TC, HDL, and LDL (p<0.05); androstenedione levels were positively correlated with glucose and insulin levels (p<0.05). In Han women with PCOS, androgen levels were negatively correlated with TG levels and positively correlated with TC levels (p<0.05); the FAI was positively correlated with glucose and insulin levels (p<0.05).ConclusionsThere were significant differences in androgen levels, endocrine, and metabolic indices in women with PCOS between the Uygur and Han ethnic groups from Xinjiang Province in China.

Alternative reproductive strategies in white-throated sparrows are associated with differences in parasite load following experimental infection.

Immune defences often trade off with other life-history components. Within species, optimal allocation to immunity may differ between the sexes or between alternative life-history strategies. White-throated sparrows (Zonotrichia albicollis) are unusual in having two discrete plumage morphs, white-striped and tan-striped. Within each sex, white-striped individuals are more aggressive and provide less parental care than tan-striped individuals. We extended immunocompetence handicap models, which predict sex differences in immunity and parasitism, to hypothesize that infection susceptibility should be greater in white-striped than tan-striped birds. We inoculated birds of both morphs with malarial parasites. Contrary to our prediction, among birds that became infected, parasite loads were higher in tan-striped than white-striped individuals and did not differ between the sexes. Circulating androgen levels did not differ between morphs but were higher in males than females. Our findings are not consistent with androgen-mediated immunosuppression. Instead, morph differences in immunity could reflect social interactions or life-history-related differences in risk of injury, and/or genetic factors. Although plumage and behavioural morphs of white-throated sparrow may differ in disease resistance, these differences do not parallel sex differences that have been reported in animals, and do not appear to be mediated by differences in androgen levels.

Androgens correlate with increased erythropoiesis in women with congenital adrenal hyperplasia.

SummaryObjectiveHyperandrogenism in congenital adrenal hyperplasia (CAH) provides an in vivo model for exploring the effect of androgens on erythropoiesis in women. We investigated the association of androgens with haemoglobin (Hb) and haematocrit (Hct) in women with CAH.DesignCross‐validation study.PatientsWomen with CAH from Sheffield Teaching Hospitals, UK (cohort 1, the training set: n = 23) and National Institutes of Health, USA (cohort 2, the validation set: n = 53).MeasurementsAndrogens, full blood count and basic biochemistry, all measured on the same day. Demographic and anthropometric data.ResultsSignificant age‐adjusted correlations (P < 0·001) were observed for Ln testosterone with Hb and Hct in cohorts 1 and 2 (Hb r = 0·712 & 0·524 and Hct r = 0·705 & 0·466), which remained significant after adjustments for CAH status, glucocorticoid treatment dose and serum creatinine. In the combined cohorts, Hb correlated with androstenedione (P = 0·002) and 17‐hydroxyprogesterone (P = 0·008). Hb and Hct were significantly higher in cohort 1 than those in cohort 2, while there were no group differences in androgen levels, glucocorticoid treatment dose or body mass index. In both cohorts, women with Hb and Hct in the highest tertile had significantly higher testosterone levels than women with Hb and Hct in the lowest tertile.ConclusionsIn women with CAH, erythropoiesis may be driven by androgens and could be considered a biomarker for disease control.

Population differences in androgen levels: A test of the Differential K theory

Differential-K theory proposes that levels of androgen, i.e. male hormone, differ across three large racial groups with Sub-Saharan Africans having the highest levels, East Asians the lowest, and Caucasians (Europeans, North Africans and South Asians) being intermediate. In this study, we found that most of the national-level indicators of androgen – CAG repeats on the AR gene, androgenic hair, prostate cancer incidence, sex frequency and number of sex partners – are positively correlated at the population (country) level. East Asians showed signs of the lowest androgen level for most indicators and were lower than Caucasians on all of them. Sub-Saharan Africans showed inconsistent results. The results provide a partial validation of Differential-K theory.

Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.

Are differences in androgen levels among women with various forms of ovarian dysfunction associated with cardiometabolic abnormalities? Androgen levels differed substantially between women with and without ovarian dysfunction, and increased androgen levels were associated with impaired cardiometabolic features in all women irrespective of their clinical condition. Sex steroid hormones play important roles in the development of cardiovascular diseases (CVD). Extremes of low as well as high androgen levels have been associated with increased CVD risk in both men and women. This cross-sectional study included 680 women with polycystic ovary syndrome (PCOS), premature ovarian insufficiency (POI), natural post-menopausal women (NM), or regular menstrual cycles (RC) (170 women per group). Measurements of serum testosterone, androstenedione and dehydroepiandrosterone sulfate were performed using liquid chromatography-tandem mass spectrometry. Assessments were taken of body mass index (BMI), blood pressure, lipid profiles, glucose, insulin and SHBG, and the bioactive fraction of circulating testosterone was calculated using the free androgen index (FAI). PCOS women were hyperandrogenic [median FAI = 4.9 (IQR 3.6-7.4)], and POI women were hypoandrogenic [FAI = 1.2 (0.8-1.7)], compared with RC women [FAI = 1.7 (1.1-2.8)], after adjustment for age, ethnicity, smoking and BMI (P < 0.001). After adjustment for age, there were no significant differences in androgens between POI and NM (P = 0.15) women and between NM and RC (P = 0.27) women, the latter indicating that chronological aging rather than ovarian aging influences the differences between pre- and post-menopausal women. A high FAI was associated with elevated triglycerides (β log FAI for PCOS: 0.45, P < 0.001, POI: 0.25, P < 0.001, NM: 0.20, P = 0.002), insulin (β log FAI for PCOS: 0.77, POI: 0.44, NM: 0.40, all P < 0.001), HOMA-IR (β log FAI for PCOS: 0.82, POI: 0.46, NM: 0.47, all P < 0.001) and mean arterial pressure (β log FAI for PCOS: 0.05, P = 0.002, POI: 0.07, P < 0.001, NM: 0.04, P = 0.04) in all women; with increased glucose (β log FAI for PCOS: 0.05, P = 0.003, NM: 0.07, P < 0.001) and decreased high-density lipoprotein (β log FAI for PCOS: -0.23, P < 0.001, NM: -0.09, P = 0.03) in PCOS and NM women; and with increased low-density lipoprotein (β log FAI for POI: 0.083, P = 0.041) in POI women. Adjustment for BMI attenuated the observed associations. Associations between FAI and cardiometabolic features were the strongest in PCOS women, even after adjustment for BMI. Associations between androgen levels and cardiometabolic features were assessed in PCOS, POI and NM women only, due to a lack of available data in RC women. Due to the cross-sectional design of the current study, the potential associations between androgen levels and actual future cardiovascular events could not be assessed. This study affirms the potent effect of androgens on cardiometabolic features, indicating that androgens should indeed be regarded as important denominators of women's health. Future research regarding the role of androgens in the development of CVD and potential modulatory effects of BMI is required. N.M.P.D. is supported by the Dutch Heart Foundation (grant number 2013T083). L.J. and O.H.F. work in ErasmusAGE, a center for aging research across the life course, funded by Nestlé Nutrition (Nestec Ltd), Metagenics Inc. and AXA. M.K. is supported by the AXA Research Fund. Nestlé Nutrition (Nestec Ltd), Metagenics Inc. and AXA had no role in the design and conduct of the study; the collection, management, analysis and interpretation of the data; or the preparation, review or approval of the manuscript. J.S.E.L. has received fees and grant support from the following companies (in alphabetical order): Ferring, Merck-Serono, Merck Sharpe & Dome, Organon, Schering Plough and Serono. In the last 5 years, B.C.J.M.F. has received fees and grant support from the following companies (in alphabetic order); Actavis, COGI, Euroscreen, Ferring, Finox, Genovum, Gedeon-Richter, Merck-Serono, OvaScience, Pantharei Bioscience, PregLem, Roche, Uteron and Watson laboratories. With regard to potential conflicts of interest, there is nothing further to disclose.

Variation in song system anatomy and androgen levels does not correspond to song characteristics in a tropical songbird

Variation in song structure and song production of birds are thought to relate to variation of both androgen levels and neural nuclei in the song system, as typically these nuclei are larger in males than in females, vary in size among males and are sensitive to steroid hormones . We investigated the relationships among song and note structure, singing rate, androgen levels and the sizes of two song nuclei, the higher vocal centre (HVC) and the robust nucleus of the arcopallium (RA) in male and female red-backed fairy-wrens, Malurus melanocephalus . Males of this duetting species express three discrete reproductive phenotypes that differ in plumage colour and behaviour. Although HVC and RA structure differed between the sexes, there were no sex differences in note structure and complexity of songs, although females differed from some male types in song rate and frequency characteristics. Both auxiliary males and females had significantly lower androgen levels than the two breeding male phenotypes. Male reproductive phenotypes had similar song characteristics and HVC and RA structure, but differed in androgen levels. Sexes and male phenotypes varied in song rate, but these differences did not correspond to differences in androgen levels. Thus, sex differences in song nuclei anatomy and androgen levels were not associated with differences in song structure and singing rate; and, the differences in androgen levels among male phenotypes were not reflected in differences in singing rate, song structure or the song nuclei. We conclude that, similar to other recent findings, the sexes of the red-backed fairy-wren can produce similar song and express similar singing behaviour despite differences in song system structure and circulating androgen levels; singing and song system anatomy appear not to be part of the suite of traits associated with differences in androgen levels in male red-backed fairy-wrens. • We examined potential factors influencing song variation in red-backed fairy-wrens. • Sexes differed in song nuclei anatomy but not in singing rate or song structure. • Females had lower androgen levels than breeding males but higher levels than auxiliary males. • Male phenotypes differed in androgen levels but not in song nuclei anatomy or song structure.

Long-life partners or sex friends? Impact of parental pair bond on offspring personality.

Previous investigations reported that some traits of parental relationships, including pair-bond duration or mate behavioural compatibility, influence subsequent offspring fitness by acting on their behaviour and growth and thus their early survival. We hypothesized that the development of a pair bond between sexual partners would have a prenatal influence. This study investigated the impact of two pairing managements on the egg characteristics and development of offspring of Japanese quail (Coturnix c. japonica). Thirty males and 30 females were paired either continuously (C; mates together all the time) or non-continuously (NC; pairs met only three times a week for 5 min). Separation-reunion tests evaluated parental pair bond. Egg yolk testosterone and androstenedione levels were evaluated, and the somatic and behavioural development of C and NC chicks was assessed. Our results revealed that members of C pairs were attached to their mates and, although no significant differences in androgen levels could be evidenced between egg sets, a higher proportion of C pairs' eggs were fertilized and their chicks appeared less emotive and more social. Our results revealed that the parental relationship can modulate the behavioural development of their offspring, probably via non-genetic effects, and this could play a major role in the emergence of inter-individual variability.

Sociodemographic Correlates of Fecal Androgen Levels in Wild Male White-Handed Gibbons (Hylobates lar)

Despite the central role of testosterone in influencing many aspects of the male life cycle, information on the influence of social and behavioral factors associated with androgen output is available for only a few primate species, mainly those living in multimale–multifemale societies. We collected 322 fecal samples and measured fecal testosterone metabolite levels in 19 adult male white-handed gibbons (Hylobates lar) from 13 groups living in the Khao Yai National Park, Thailand, to examine the extent to which androgen output is related to sociodemographic variables (social organization, social status, presence of infants, age) in a socially flexible species, i.e., pair-living/multimale groups. We predicted that androgen levels would be higher in males 1) that live in potentially more unstable single-male/single-female units; 2) that are primary (dominant) vs. secondary; 3) that live in groups with dependent infants; and 4) that are of prime vs. senior age. We found marked differences in androgen levels among males and a significant effect of time of the year. Males living in pairs exhibited significantly higher androgen concentrations vs. males living in multimale groups, and males residing in groups with infants showed a significant increase in androgen levels throughout the sampling year. However, we found no relationship with male age or social status. The increased androgen output found in both pair-living males and those residing with infants might be a physiological mechanism that facilitates male aggression to cope with potential threats posed by social challenges and the demand for infant/group defense, respectively. More generally, our data indicate that in socially flexible species male androgen output is less strongly linked to key life-history variables than in species that live permanently in multimale–multifemale groups.

Immune activation is inversely related to, but does not cause variation in androgen levels in a cichlid fish species

Studies on birds and mammals indicate that sexual traits may signal superior health because active immunity, like inflammatory responses to infections, is suppressive to the production of androgens that facilitate the expression of these traits. Here we test this possible pathway for honest signaling in a teleost species, Sarotherodon galilaeus, by activating the immune system with sheep red blood cells (SRBC), which is a non-pathogenic T- and B-cell stimulating antigen. Two weeks after the start of treatment adult males injected with SRBC showed a significant increase in antibody production in comparison with control males. The variation in specific antibody production was negatively related with variation in both testosterone and 11-ketotestosterone levels. This suggests that investment in immune protection is incompatible with increased activity of the hypothalamic-pituitary-gonadal axis. However, opposite to our expectation no difference in androgen levels was found between placebo and SRBC treatment suggesting that immune activation did not cause androgen suppression in our studied species.

Variations of serum testosterone levels in prostate cancer patients under LH-releasing hormone therapy: an open question

The hypothesis 'the lower the better when achieving castration levels of testosterone' is based on the data from second-line hormonal manipulation and its molecular basis, and on better oncological results reported for lower castration levels in prostate cancer (PCa) patients, including those achieved with maximal androgen blockade. In this regard, the equivalence of surgical and different pharmacological castrations has been controversial. The modified amino acid structure that makes LH-releasing hormone (LHRH) analogs more potent than LHRH, and the method of delivering the analogs impacts on bioavailibility and potentially causes differences in androgen levels and in its final oncological efficacy. In addition to this, there is a myriad of circumstances, such as those related to ethnic variations and co-morbidities, which uniquely impact on the pharmacological approach in a highly heterogeneous population of castration-resistant prostate cancer (CRPC) patients. Ineffective testosterone suppression through hormonal escape is currently poorly recognized and may result in increased PCa mortality. Until now, the optimal serum testosterone level in patients under castration, and the impact of its variations in patients under LHRH therapy, remain open questions and have been merged to a broad spectra of patients who are highly heterogeneous. This heterogeneity relates to a number of mechanisms regarding response to treatment, which influences the biology of the relapsing tumor and the sensitivity to subsequent therapies in the individual patient. The rationale to achieve testosterone levels below 20-50 ng/dl warrant further investigation as these levels have recently rescued CRPC patients. In the last few years and months, important advancements in prostate cancer treatment have been achieved. Nevertheless, these advances are measured in a few months of additional survival and under high costs, not available to most of the world population, compared with the benefits of hormonal manipulation that are measured in years, there is a huge potential for accessible and durable effect expansion and optimization of treatment, particularly with the current tendency of a more individual approach.

Differences in Stimulated Androgen Levels in Black and White Obese Adolescent Females

Study Objective Little is known about racial differences in androgen levels among obese children. The objective of this pilot study was to compare basal and stimulated androgen levels in a cross-sectional sample of obese black and white pubertal females. Study Design, Setting, and Participants This was cross-sectional study of obese (body mass index ≥ 95th percentile) but otherwise healthy female adolescents (10 black and 12 white; age range 8.8-13.9 y) who underwent adrenocorticotropic hormone stimulation testing at an academic medical center as part of a protocol for the study of obesity-related conditions. Main Outcome Measures Basal and stimulated androgen levels. Results White and black participants were similar with regard to pubertal stage, body mass index, percentage body fat, and fasting glucose and insulin levels. Black girls had lower stimulated levels of 17-hydroxyprogesterone, and the differences between basal and stimulated levels of 17-hydroxyprogesterone and androstenedione were lower in black girls. Body mass index was negatively correlated with stimulated cortisol in blacks only ( r = -0.69, P = .03). Conclusion There appear to be race-related differences in stimulated androgen levels in obese adolescent females. These differences deserve further study, as measurements of androgen levels are commonly used in clinical practice and research.

Are mid‐pregnancy androgen levels negatively associated with breastfeeding?

Are mid‐pregnancy androgen levels negatively associated with breastfeeding?

Insulin-Like Factor 3: A New Circulating Hormone Related to Luteinizing Hormone-Dependent Ovarian Hyperandrogenism in the Polycystic Ovary Syndrome

Insulin-like factor 3 (INSL3), a circulating peptide hormone and a member of the relaxin-insulin family, is produced in the testicular Leydig cells and, to a lesser extent, in ovarian theca interna cells of antral follicles, the corpora lutea, and the ovarian stroma. Recent studies in rats suggest an important role for luteinizing hormone (LH) in stimulating gonadal expression of INSL3. Most women with polycystic ovary syndrome (PCOS) have a hyperplastic theca intema and cortical stroma and an increased number of small antral follicles. A majority-specially non-obese patients-have elevated circulating LH levels. This study estimated circulating levels of INSL3 by radioimmunoassay in 22 women with PCOS and normal body weight and 22 others who were overweight (body mass index [BMI] of 25-30 kg/m 2 ) or obese (BMI exceeding 30 kg/m 2 ). Each was matched for age and body weight with a non-PCOS control subject. Compared with control women, those with PCOS had greater insulin responses to oral glucose, higher androgen levels, and less frequent menstruation. Differences in androgen levels were most evident in normal-weight subjects, while differences in insulin responses to glucose were more evident in overweight/obese women. Baseline LH levels were highest in PCOS women of normal body weight. Serum levels of INSL3 were significantly higher in PCOS women than in control subjects, but only in those of normal body weight. In all women, serum INSL3 correlated positively with levels of total and free testosterone and with LH levels. In women with PCOS, concentrations of INSL3 were associated with greater responses of 170H-progesterone to buserelin, an index of ovarian hyperandrogenism. Levels of INSL3 also correlated positively with the number of ovarian follicles in women with PCOS. In contrast, women with PCOS exhibited no significant correlation between baseline LH levels and the number of follicles. These findings could be interpreted to mean that INSL3 is a circulating hormone related to LH-dependent ovarian hyperandrogenism in women with PCOS and normal body weight.